Effective September 1, 2025, requires quarterly testing of biosolids for PFAS contaminants by those seeking to apply biosolids to lands, with subsequent reports to the department of environmental management.
Summary
S0650 amends Rhode Island’s water pollution laws to add a new biosolids testing requirement focused on PFAS contamination. Any applicant seeking Department of Environmental Management approval to distribute or land-apply biosolids must test for PFAS and submit the results with the application. Operators who already hold approval must test their biosolids quarterly and file the results with the department each calendar quarter, beginning with the October–December 2025 quarter and with the first report due by December 31, 2025.
The bill also gives the DEM director express authority to deny an application if approving the biosolids activity would create an environmental threat or pose a risk to public health, safety, or welfare. The act takes effect September 1, 2025, and is aimed at strengthening oversight of biosolids management and PFAS monitoring in land application programs.
Impact
This bill adds a new section to Chapter 46-12 of the General Laws governing water pollution, creating a specific PFAS testing and reporting regime for biosolids used in land application or distribution. It affects applicants and existing permit holders by imposing testing obligations, reporting deadlines, and potential denial of approval based on environmental or public health concerns, while expanding the Department of Environmental Management’s enforcement and review authority.
Sentiment
The bill appears to have broad support and little visible opposition. It passed the Senate 36-0 and the House in concurrence 71-0, indicating strong bipartisan agreement on the need for PFAS oversight and biosolids testing. No committee transcript was provided, so the available record suggests consensus rather than active debate.
Contention
No specific points of contention are documented in the provided materials. The only potentially sensitive issue is the added compliance burden on biosolids operators and applicants, who must conduct quarterly PFAS testing and submit results to DEM, but the unanimous votes suggest that any such concerns did not generate recorded opposition. The bill’s public-health and environmental protection rationale appears to have outweighed any regulatory or cost concerns.